Why your coworkers are suddenly talking about their bodies so much
As more people use Ozempic and other GLP-1s, coworkers are asking awkward questions about bodies and weight loss. Nobody knows where the line is.
Colleagues at Isabel Haneder's workplace in Germany found themselves discussing their bodies more frequently following the introduction of GLP-1s, a class of drugs used for weight loss. Haneder, who began using GLP-1 a year and a half ago, noticed changes in her body, including loose skin, but was taken aback by the conversation it sparked.
She found herself deflecting questions about her weight to avoid further discussion. The prevalence of GLP-1s has blurred the lines of acceptable conversation at work. While discussing medications at work typically would not be a problem, the emotional and financial implications of GLP-1s have created a complex situation for employees and employers alike.
Health insurance premiums could rise for companies that offer coverage for GLP-1s, creating tension between those seeking access to the drugs and those opposed to paying for what they view as lifestyle choices. Additionally, weight stigma can have detrimental effects on mental health and career prospects. The surge in GLP-1s has reignited discussions about body image in the workplace, putting pressure on employees to navigate these conversations carefully and professionally.
Written by urgent.news from Business Insider's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
